Insufficient scRNA-seq data for expression of FZD2 at single-cell level.
Insufficient scRNA-seq data for expression of FZD2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 98% | 324.95 | 176 / 180 | 95% | 28.22 | 410 / 430 |
uterus | 99% | 500.80 | 169 / 170 | 86% | 22.09 | 395 / 459 |
lung | 96% | 310.83 | 552 / 578 | 90% | 11.02 | 1038 / 1155 |
bladder | 95% | 204.33 | 20 / 21 | 81% | 10.79 | 406 / 504 |
thymus | 97% | 260.66 | 635 / 653 | 78% | 6.95 | 472 / 605 |
breast | 80% | 134.00 | 369 / 459 | 92% | 10.75 | 1026 / 1118 |
intestine | 90% | 170.42 | 869 / 966 | 66% | 5.57 | 348 / 527 |
pancreas | 61% | 68.06 | 200 / 328 | 93% | 10.46 | 165 / 178 |
esophagus | 74% | 113.19 | 1064 / 1445 | 80% | 10.20 | 146 / 183 |
kidney | 98% | 244.35 | 87 / 89 | 55% | 4.61 | 498 / 901 |
prostate | 92% | 184.67 | 226 / 245 | 53% | 2.66 | 266 / 502 |
stomach | 60% | 92.13 | 214 / 359 | 69% | 7.99 | 196 / 286 |
skin | 54% | 531.44 | 982 / 1809 | 73% | 7.57 | 344 / 472 |
brain | 53% | 83.95 | 1410 / 2642 | 72% | 7.37 | 508 / 705 |
adrenal gland | 89% | 158.79 | 230 / 258 | 31% | 2.78 | 72 / 230 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.91 | 1 / 1 |
blood vessel | 98% | 664.06 | 1306 / 1335 | 0% | 0 | 0 / 0 |
spleen | 97% | 202.46 | 233 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 91% | 6.89 | 41 / 45 |
lymph node | 0% | 0 | 0 / 0 | 90% | 7.22 | 26 / 29 |
adipose | 81% | 141.73 | 974 / 1204 | 0% | 0 | 0 / 0 |
heart | 80% | 149.66 | 685 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 68% | 154.39 | 636 / 929 | 0% | 0 | 0 / 0 |
liver | 4% | 4.93 | 8 / 226 | 13% | 1.21 | 51 / 406 |
eye | 0% | 0 | 0 / 0 | 11% | 0.44 | 9 / 80 |
muscle | 7% | 8.60 | 59 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0003151 | Biological process | outflow tract morphogenesis |
GO_0051091 | Biological process | positive regulation of DNA-binding transcription factor activity |
GO_0045446 | Biological process | endothelial cell differentiation |
GO_0003149 | Biological process | membranous septum morphogenesis |
GO_0007608 | Biological process | sensory perception of smell |
GO_0090103 | Biological process | cochlea morphogenesis |
GO_0007267 | Biological process | cell-cell signaling |
GO_0060070 | Biological process | canonical Wnt signaling pathway |
GO_0090179 | Biological process | planar cell polarity pathway involved in neural tube closure |
GO_0030182 | Biological process | neuron differentiation |
GO_0003150 | Biological process | muscular septum morphogenesis |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0060022 | Biological process | hard palate development |
GO_0060119 | Biological process | inner ear receptor cell development |
GO_0060071 | Biological process | Wnt signaling pathway, planar cell polarity pathway |
GO_0035567 | Biological process | non-canonical Wnt signaling pathway |
GO_0016055 | Biological process | Wnt signaling pathway |
GO_0005886 | Cellular component | plasma membrane |
GO_0030669 | Cellular component | clathrin-coated endocytic vesicle membrane |
GO_0005925 | Cellular component | focal adhesion |
GO_0005737 | Cellular component | cytoplasm |
GO_0017147 | Molecular function | Wnt-protein binding |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
GO_0042813 | Molecular function | Wnt receptor activity |
GO_0030165 | Molecular function | PDZ domain binding |
GO_0005515 | Molecular function | protein binding |
Gene name | FZD2 |
Protein name | Frizzled-2 Frizzled-2 (Fz-2) (hFz2) (FzE2) |
Synonyms | |
Description | FUNCTION: Receptor for Wnt proteins. Most of frizzled receptors are coupled to the beta-catenin canonical signaling pathway, which leads to the activation of disheveled proteins, inhibition of GSK-3 kinase, nuclear accumulation of beta-catenin and activation of Wnt target genes . A second signaling pathway involving PKC and calcium fluxes has been seen for some family members, but it is not yet clear if it represents a distinct pathway or if it can be integrated in the canonical pathway, as PKC seems to be required for Wnt-mediated inactivation of GSK-3 kinase. Both pathways seem to involve interactions with G-proteins. May be involved in transduction and intercellular transmission of polarity information during tissue morphogenesis and/or in differentiated tissues. .; FUNCTION: (Microbial infection) Acts as a receptor for C.difficile toxin TcdB in the colonic epithelium . TcdB occupies the binding site for Wnt-adducted palmitoleate in frizzled receptors and TcdB-binding prevents Wnt-binding and downstream Wnt signaling . . |
Accessions | Q14332 ENST00000315323.5 Q86UZ8 |